- Home
- ICCC vs PHUN Comparison
ICCC vs PHUN Comparison
Compare ICCC & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- PHUN
- Stock Information
- Founded
- ICCC 1982
- PHUN 2009
- Country
- ICCC United States
- PHUN United States
- Employees
- ICCC N/A
- PHUN N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- PHUN EDP Services
- Sector
- ICCC Health Care
- PHUN Technology
- Exchange
- ICCC Nasdaq
- PHUN Nasdaq
- Market Cap
- ICCC 60.1M
- PHUN 64.1M
- IPO Year
- ICCC 1987
- PHUN N/A
- Fundamental
- Price
- ICCC $6.71
- PHUN $3.46
- Analyst Decision
- ICCC
- PHUN Buy
- Analyst Count
- ICCC 0
- PHUN 2
- Target Price
- ICCC N/A
- PHUN $7.75
- AVG Volume (30 Days)
- ICCC 41.8K
- PHUN 360.3K
- Earning Date
- ICCC 08-12-2025
- PHUN 08-07-2025
- Dividend Yield
- ICCC N/A
- PHUN N/A
- EPS Growth
- ICCC N/A
- PHUN N/A
- EPS
- ICCC N/A
- PHUN N/A
- Revenue
- ICCC $27,302,766.00
- PHUN $2,956,000.00
- Revenue This Year
- ICCC N/A
- PHUN $3.01
- Revenue Next Year
- ICCC N/A
- PHUN $50.72
- P/E Ratio
- ICCC N/A
- PHUN N/A
- Revenue Growth
- ICCC 28.29
- PHUN N/A
- 52 Week Low
- ICCC $3.34
- PHUN $2.22
- 52 Week High
- ICCC $7.60
- PHUN $14.60
- Technical
- Relative Strength Index (RSI)
- ICCC 49.68
- PHUN 60.41
- Support Level
- ICCC $5.63
- PHUN $2.95
- Resistance Level
- ICCC $7.14
- PHUN $3.10
- Average True Range (ATR)
- ICCC 0.64
- PHUN 0.17
- MACD
- ICCC -0.06
- PHUN 0.03
- Stochastic Oscillator
- ICCC 42.58
- PHUN 93.65
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.